AGA Presents Cutting-Edge Research During DDW®
AGA Late-Breaking Sessions
- Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients With Noncancer Pain (8:30 a.m. PT, Abstract #943a) Richard L. Rauck et al.
- Vedolizumab Induction Therapy for Ulcerative Colitis: Results of Gemini I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial (8:45 a.m. PT, Abstract #943b) Brian G. Feagan et al.
- Accelerated Step-Care Therapy With Early Azathioprine (AZA) vs. Conventional Step-Care Therapy in Crohn's Disease: A Randomized Study (9 a.m. PT, Abstract #943c) Jacques Cosnes et al.
- A Phase 2/3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Pursuit SC (9:15 a.m. PT, Abstract #943d) William J. Sandborn et al.
- Mudelta Treatment Improves Bowel Movement Frequency and Urgency Episodes in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: Results of a Phase 2 Clinical Trial (9:30 a.m. PT, Abstract #943e) Paul S. Covington et al.
- Tmc435 in HCV Genotype 1 Patients Who Have Failed Previous Pegylated Interferon/Ribavirin Treatment: Final Svr24 Results of the Aspire Trial (9:45 a.m. PT, Abstract #943f ) Fred Poordad et al.
- The Future of Clinical Practice in Gastroenterology. John I. Allen, Minnesota Gastroenterology PA; University of Minnesota School of Medicine
- Medicine in the United Kingdom - Contrasts and Lessons From the National Health Service. Jonathan M. Rhodes, University of Liverpool
- Curing Chronic Viral Hepatitis - the New World of Antiviral Therapy. Jacqueline G. O'Leary, Liver Consultants of Texas
- GI Motility, Irritable Bowel Syndrome, and Women. Lin Chang, UCLA Division of Digestive Diseases
- The Future of Personalized Medicine - Reality vs Illusion. Anil K. Rustgi, University of Pennsylvania School of Medicine
- How Will We Prevent Colorectal Cancer in the Future? Dennis J. Ahnen, Denver VA Medical Center
- The Microbiome and Inflammation. Gary D. Wu, University of Pennsylvania School of Medicine
- Obesity, Diet and the Microbiome. Lee M. Kaplan, Massachusetts General Hospital
- The Future of IBD Therapy. William J. Sandborn, University of California, San Diego
- Heme Oxygenase-1 Maintains Intestinal Homeostasis Through Augmented Enteric Bacterial Clearance (2:20 p.m. PT, Abstract #514) Joseph C. Onyiah et al.
- Weight-Independent Changes in Gut Microbial Ecology Regulate Adiposity Following Roux-en-Y Gastric Bypass Surgery in Mice (2:35 p.m. PT, Abstract #515) Alice P. Liou et al.
- The Gut Microbiota At the Interface Between Mucosal Immunity and Host Metabolism (2:50 p.m. PT, Abstract #Sp502) Martin J. Blaser
- DCLK1 Labels a Multipotent and Residual Neural Crest-Derived Stem Cell in the Gut Epithelium and Enteric Nervous System (3:10 p.m. PT, Abstract #515a) Michael Quante et al.
- Cell-Autonomous ADAM10 Signaling Is Essential for Maintenance of Long-Lived Multipotent Intestinal Stem Cells (3:25 p.m. PT, Abstract #517) Yu-Hwai Tsai et al.
- Patch Clamp Recordings Reveal Paracellular (Tight Junction) Ion Channels (3:40 p.m. PT, Abstract #518) Christopher R. Weber et al.
- Effect of Flexible Sigmoidoscopy Screening on Incidence and Mortality From Colorectal Cancer in the PLCO Screening Trial (8:05 a.m. PT, Abstract #588) Robert E. Schoen et al.
- Modulation of the Brain-Gut Axis After 4-Week Intervention With a Probiotic Fermented Dairy Product (8:27 a.m. PT, Abstract #589) Kirsten Tillisch et al.
- Screening and Surveillance in Barrett's Esophagus: Does It Make Sense? (8:49 a.m. PT, Abstract #Sp554) David A. Katzka
- One-Year Effectiveness and Costs of Six Alternative H. pylori Test/Treat and Retest/Retreat Strategies Using Triple, Concomitant or Sequential Drug Regimens in Seven Latin American Sites (SWOG Trial S0701) (9:11 a.m. PT, Abstract #590) Javier Torres et al.
- Obese Pediatric Patients Have Increased Cardiovascular Disease Risk Comparable to Pediatric Patients With Familial Dyslipidemia (9:33 a.m. PT, Abstract #591) Angela Shannon et al.
AGA Academy of Educators Plenary Session
AGA Practitioner Picks
- Everything You Need to Know about IBS Treatment (May 19, 2:15 p.m. PT, Room 24abc)
- Clinical Chronic Pancreatitis (May 19, 2:15 p.m. PT, Room 4)
- Pathogenesis and Diagnosis of Eosinophilic Esophagitis (May 20, 8:30 a.m. PT, Room 30ab)
- Epidemiology and Management of Eosinophilic Esophagitis (May 20, 2:15 p.m. PT, Room 30cde)
- Sessile Serrated Polyps - What to Do? (May 20, 2:15 p.m. PT, Room 8)
- Clinical Science Plenary (May 21, 8 a.m. PT, Room 20d)
- 2012 Presidential Plenary (May 21, 10 a.m. PT, Room 20d)
- Advances in the Management of Inflammatory Bowel Disease (May 22, 10:30 a.m., Room 20a)
- Prebiotics and Probiotics (May 22, 10:30 a.m., Room 3)
- Managing the Complications of IBD Therapies (May 22, 2:15 p.m. PT, Room 2)
- Pancreatic Malignancy (May 22, 2:15 p.m. PT, Room 26ab)
AGA Institute-Rome Foundation Lectureship
- Regulation of Intestinal Permeability in Health and Disease
- Esophageal Permeability: Does It Explain the Symptoms of NERD?
- Intestinal Permeability: Does It Explain the Symptoms of Functional GI Disorders?
About the AGA Institute